Overview

Safety and Efficacy of Asfotase Alfa in Patients With Hypophosphatasia (HPP)

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess safety and efficacy of Asfotase Alfa (ALXN1215) in patients with hypophosphatasia
Phase:
Phase 2
Details
Lead Sponsor:
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Translational Research Informatics Center, Kobe, Hyogo, Japan
Collaborator:
Osaka University Graduate School of Medicine
Treatments:
Immunoglobulin G